Ysios Capital is a Spain-based venture capital firm specializing in life sciences investments, with a strong focus on biotechnology and medical innovation companies; it invests primarily in early-stage and growth-stage biotech startups developing therapeutics, drug discovery platforms, and advanced medical technologies, often in areas such as oncology, rare diseases, and precision medicine; the firm operates across European and US biotech ecosystems and typically participates in seed through Series B rounds, frequently co-investing with other leading global life sciences funds; Ysios provides both capital and strategic guidance, leveraging deep sector expertise in clinical development and pharmaceutical commercialization; overall it functions as a dedicated life sciences venture capital firm focused on biotechnology innovation and drug development pipelines.